Russell Allen is president and CEO of Georgia Bio. Allen directs programs and initiatives that contribute to the positioning of Georgia as one of the leading locations for biotechnology, pharmaceutical, health informatics and medical device sectors. Major responsibilities include strategic and business development and issue management related to capital formation, workforce development, education and commercialization. Allen also leads the affiliate advocacy organization, the Georgia Life Sciences Coalition, and the angel network, Bio/Med Investor Network.
Previously, Allen was President and CEO of Florida’s bioscience association, BioFlorida, and led one of the nation’s largest industry growth periods from 2006 to 2013. Prior to BioFlorida, Allen led BioSouth, a nonprofit membership organization dedicated to support commercialization, licensing and partnering efforts for the bioscience industry throughout the southern U.S. There, he instituted member programs and produced the organization’s annual conferences, BioFusion and the CDC Technology Forum.
Allen began his professional career in sales of laboratory research equipment and supplies in the San Francisco Bay area. He moved from biotech sales into Atlanta’s high-tech industry in 1996 when he co-founded Newton Park, one of the region’s most successful marketing, development and interactive strategy firms. As CEO, Allen led the organization from start-up to one of the area’s fastest growing companies and top five digital marketing agencies in Atlanta. In 2001, Russell founded BioQuotient, a bioscience business consulting and marketing firm before taking a position as a vice president of biosciences at the Metro Atlanta Chamber of Commerce. In this role, he led the strategy to support and grow the Georgia bioscience industry and served on the board of directors for Georgia Bio.
Allen received a bachelor’s degree in biology from Pepperdine University and a certificate in Biotech Enterprise Management from the Owen Graduate School of Business at Vanderbilt University. Currently, he serves on the board of directors for Georgia Bio, Bio/Med Investor Network, Georgia Life Sciences Coalition, Council of State Bioscience Associations and Southeast BIO; and serves on numerous industry advisory boards and councils.